SCHEMBL30177254

SCHEMBL30177254

CCCCOC(=O)N1CC2(CCC(I)C2)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.34
▸ GBA2 Q9HCG7 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ OPRD1 P41143 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ HRH2 P25021 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ EPHX2 P34913 3/20 0.32
▸ BCHE P06276 1/20 0.32
▸ HPGD P15428 2/20 0.31
▸ DPP4 P27487 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CHRM1 P11229 2/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ CHRM4 P08173 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30013395 0.89 LMNA (0.48) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL30177286 0.88 SMN1; SMN2 (0.49) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL30177290 0.84 SMN1; SMN2 (0.43) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL30135763 0.81 SMN1; SMN2 (0.46) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL30177306 0.81 MGLL (0.42) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL30177247 0.80 LMNA (0.44) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL23859720 0.79 LMNA (0.49) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL31111887 0.78 GAA (0.49) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL25412507 0.78 LMNA (0.43) SMN1; SMN2LMNAPOLBALDH1A1GBA2
SCHEMBL30177277 0.77 MGLL (0.46) OPRD1OPRK1BCHECHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126852-A1 AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS Janssen Pharmaceutica NV (BE) 2023-02-08 — — EP disclosed
Send feedback